Join us for an immersive one-day educational event dedicated to cardiac transthyretin amyloidosis (TTR-amyloidosis) — an evolving and increasingly recognised condition at the intersection of cardiology and imaging. This study day brings together leading experts in the field to advance understanding, share cutting-edge developments, and foster collaboration across specialties.
Through a series of interactive lectures, expert-led discussions, and challenging case reviews, attendees will deepen their knowledge of the disease process, enhance diagnostic confidence, and refine their interpretation of multimodality imaging in cardiac amyloidosis.
This programme is designed for consultants, residents, and AHPs involved in cardiac imaging, heart failure, or the multidisciplinary care of patients with amyloidosis.
Key Focus Areas:
- Pathophysiology of TTR-Amyloidosis – understanding disease mechanisms and clinical implications
- Imaging as a Diagnostic Tool – exploring echocardiography, MRI, nuclear imaging, and CT in amyloidosis detection and differentiation
- Therapeutic Response Assessment – evaluating treatment outcomes and disease progression through imaging
- Challenging Cases and MDT Perspectives – discussing complex scenarios, interpretation pitfalls, and collaborative decision-making
Gain insights from national experts, strengthen your practical imaging skills, and engage in open discussions on real-world diagnostic dilemmas. Whether you’re an imaging specialist or part of a multidisciplinary cardiac team, this study day will enhance your confidence and clinical practice in managing cardiac amyloidosis.
Register here
Direct email queries to: [email protected]
